Adjuvant chemotherapy increases disease-free survival although no overall survival in patients with stage II colon cancer.
A Cochrane review 1 included 33 randomized trials and 17 meta-analyses containing data on stage II colon cancer patients undergoing adjuvant therapy versus surgery alone. The participants in the trials were patients with completely resected colon (n=7,731) or rectal (n=7,600) cancers. With regards to the effect of adjuvant therapy on stage II colon cancer, the pooled relative risk ratio for overall survival was 0.96 (95% CL 0.88 to 1.05). With regards to disease-free survival, the pooled relative risk ratio was 0.83 (95% Cl 0.75 to 0.92).
1. Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 2008;(3):CD005390. [PMID:18646127]
Copyright © 2019 Duodecim Medical Publications Limited.
Adjuvant chemotherapy in colorectal cancer
is a sample topic from the Evidence-Based Medicine Guidelines
To view other topics, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Complete Product Information.
"Adjuvant Chemotherapy in Colorectal Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454545/all/Adjuvant_chemotherapy_in_colorectal_cancer.
Adjuvant chemotherapy in colorectal cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454545/all/Adjuvant_chemotherapy_in_colorectal_cancer. Accessed October 20, 2019.
Adjuvant chemotherapy in colorectal cancer. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/454545/all/Adjuvant_chemotherapy_in_colorectal_cancer
Adjuvant Chemotherapy in Colorectal Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454545/all/Adjuvant_chemotherapy_in_colorectal_cancer.
TY - ELEC
T1 - Adjuvant chemotherapy in colorectal cancer
ID - 454545
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454545/all/Adjuvant_chemotherapy_in_colorectal_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine